- Home
- ARDX vs MVST Comparison
ARDX vs MVST Comparison
Compare ARDX & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- MVST
- Stock Information
- Founded
- ARDX 2007
- MVST 2006
- Country
- ARDX United States
- MVST United States
- Employees
- ARDX N/A
- MVST N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- MVST Industrial Machinery/Components
- Sector
- ARDX Health Care
- MVST Miscellaneous
- Exchange
- ARDX Nasdaq
- MVST Nasdaq
- Market Cap
- ARDX 882.9M
- MVST 848.0M
- IPO Year
- ARDX 2014
- MVST N/A
- Fundamental
- Price
- ARDX $6.52
- MVST $2.56
- Analyst Decision
- ARDX Strong Buy
- MVST Strong Buy
- Analyst Count
- ARDX 9
- MVST 1
- Target Price
- ARDX $10.50
- MVST $6.00
- AVG Volume (30 Days)
- ARDX 3.5M
- MVST 7.2M
- Earning Date
- ARDX 10-30-2025
- MVST 08-11-2025
- Dividend Yield
- ARDX N/A
- MVST N/A
- EPS Growth
- ARDX N/A
- MVST N/A
- EPS
- ARDX N/A
- MVST N/A
- Revenue
- ARDX $386,146,000.00
- MVST $422,605,000.00
- Revenue This Year
- ARDX $16.83
- MVST $25.36
- Revenue Next Year
- ARDX $28.55
- MVST $30.46
- P/E Ratio
- ARDX N/A
- MVST N/A
- Revenue Growth
- ARDX 83.88
- MVST 20.84
- 52 Week Low
- ARDX $3.21
- MVST $0.15
- 52 Week High
- ARDX $7.18
- MVST $4.72
- Technical
- Relative Strength Index (RSI)
- ARDX 79.80
- MVST 40.50
- Support Level
- ARDX $6.38
- MVST $2.53
- Resistance Level
- ARDX $6.65
- MVST $2.69
- Average True Range (ATR)
- ARDX 0.22
- MVST 0.15
- MACD
- ARDX 0.00
- MVST 0.01
- Stochastic Oscillator
- ARDX 85.53
- MVST 30.00
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.